Related Experiment Video
Updated: Nov 11, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
COVID-19-related risk of in-hospital death in Silesia, Poland
Małgorzata Kowalska1, Kamil Barański1, Grzegorz Brożek2
1Department of Epidemiology, School of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Katowice, Poland
Introduction:
The situation regarding COVID‑19 in Poland is rapidly evolving. Because of this, it is important to investigate COVID‑19 mortality and its predictors in one of the most densely populated regions of the country, Silesia Province.
Objectives:
The goals of this study were to assess in‑hospital mortality due to COVID‑19 and the impact of sex, age, and coexisting diseases on the risk of death.
Patients And Methods:
The data analysis was based on discharge reports of patients with COVID‑19 hospitalized between March and June 2020 in all hospitals in the region. Age, sex, hospital discharge status, and the presence of coexisting diseases were abstracted from the charts.
Results:
In a group of 2830 in‑patients with COVID‑19, 325 died during hospitalization. COVID‑19 deaths were associated with male sex (odds ratio [OR], 1.52; 95% CI, 1.17-1.96), older age (OR, 6.11; 95% CI, 4.5-8.31), and the presence of 3 or more coexisting diseases (OR, 4.78; 95% CI, 3.52-6.49). The most prevalent comorbidities were chronic cardiovascular and respiratory diseases.
Conclusions:
The estimated in‑hospital fatality rate for COVID‑19 was 11.5%, which is lower than the average COVID‑19 fatality rate in other European countries. The risk of in‑hospital death was associated with sex, age, and the number of coexisting diseases, such as chronic cardiovascular and respiratory diseases.
More Related Videos
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Relative Risk
Hazard Rate
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

